Table 2.
Incidence rate and incidence rate ratio
| Outcomes | Spironolactone (n = 158) | No spironolactone (n = 299) | ||||
|---|---|---|---|---|---|---|
| Patients with event, n (%) | Incidence/1000 person‐years at risk | Patients with event, n (%) | Incidence/1000 person‐years at risk | Rate ratio (95% CI) | P value | |
| Primary outcome | ||||||
| All‐cause death or HF rehospitalization | 48 (30.4) | 171.5 | 123 (41.1) | 278.8 | 0.61 (0.44–0.86) | 0.004 |
| Secondary outcomes | ||||||
| CV death or HF rehospitalization | 42 (26.6) | 150.0 | 110 (36.8) | 249.4 | 0.60 (0.42–0.86) | 0.005 |
| All‐cause death | 21 (13.3) | 65.0 | 51 (17.1) | 91.5 | 0.71 (0.43–1.18) | 0.19 |
| CV death | 9 (5.7) | 27.8 | 30 (10.0) | 53.8 | 0.52 (0.25–1.09) | 0.083 |
CV, cardiovascular; HF, heart failure.